Search

Displaying results 9601 - 9610 of 10000 in total
  1. Drug

    Dibutylsuccinate

    go.drugbank.com/drugs/DB13332
    Experimental

    Categories: Insecticides and Repellents, Scabicides, Insecticides and Repellents
  2. Drug

    Policresulen

    go.drugbank.com/drugs/DB13492
    Investigational

    Categories: Phenol and Derivatives, Antiseptics and Disinfectants
  3. Drug

    SJG-136

    go.drugbank.com/drugs/DB11965
    Investigational

    SJG-136 has been used in trials studying the treatment of Recurrent Fallopian Tube Cancer, Secondary Acute Myeloid Leukemia, de Novo Myelodysplastic Syndromes, Recurrent Ovarian Epithelial Cancer, and

  4. Drug

    Modimelanotide

    go.drugbank.com/drugs/DB15314
    Investigational

    Modimelanotide is under investigation in clinical trial NCT01897519 (A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing

  5. Drug

    Bifikafusp alfa

    go.drugbank.com/drugs/DB19185
    Investigational

    Bifikafusp alfa is under investigation in clinical trial NCT05329792 (L19IL2/L19TNF in Skin Cancer Patients).

    Categories: bifikafusp alfa and onfekafusp alfa, Antineoplastic and Immunomodulating Agents
  6. Drug

    Retezorogant

    go.drugbank.com/drugs/DB21592
    Experimental

    The usage of the INN stem '-rogant' in the name indicates that Retezorogant is a retinoic acid receptor-related orphan receptor gamma (RORY) antagonist and inverse agonist.

  7. Drug

    Tiprotimod

    go.drugbank.com/drugs/DB20695
    Experimental

    The usage of the INN stem '-imod' in the name indicates that Tiprotimod is a immunomodulator, both stimulant/suppressive and stimulant. Tiprotimod has a monoisotopic molecular weight of 275.03 Da.

  8. Drug

    BMS-214662

    go.drugbank.com/drugs/DB12234
    Investigational

    been used in trials studying the treatment of Childhood Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Recurrent Adult Acute Myeloid Leukemia, Relapsing Chronic Myelogenous Leukemia, and

  9. Drug

    Perfluorodecalin

    go.drugbank.com/drugs/DB16292
    Investigational

    Perfluorodecalin is under investigation in clinical trial NCT03668665 (Influencing Wound Healing Through the Application of Hyaluronic Acid With Perfluorodecalin and Physalis Angulata Extract After Split

  10. Drug

    Fosgonimeton

    go.drugbank.com/drugs/DB21516
    Investigational

    Fosgonimeton is under investigation in clinical trial NCT05511558 (A Study of the Absorption, Metabolism, and Excretion of [14C]-Fosgonimeton (ATH-1017)).